Caribou Biosciences, Inc.

CRBU • NASDAQ

Caribou Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Rachel E. Haurwitz, with a market cap of $189.4M.

Market Cap$189.4M

Employees137.0

CEORachel E. Haurwitz

CountryUnited States of America

Healthcare

Biotechnology

Next EarningsMay 7, 2026 · In 3 weeksQ1 2026

Income Statement Balance Sheet Cash Flow Business Segments

Financials

View all metrics

Caribou Biosciences, Inc. FAQ

Common questions about Caribou Biosciences, Inc.

Caribou Biosciences, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $2.3M.

Caribou Biosciences, Inc. has approximately 137 employees.

Caribou Biosciences, Inc.

Financials

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Caribou Biosciences, Inc. FAQ

When is Caribou Biosciences, Inc.'s next earnings date?

How many employees does Caribou Biosciences, Inc. have?

Cookie Preferences